Back to GL GLENVIEW CAPITAL MANAGEMENT, LLC
LABORATORY CRP OF AMER HLDGS
Showing 0 of 7 quarters
Position history for GLGLENVIEW CAPITAL MANAGEMENT, LLC's holdings in LABORATORY CRP OF AMER HLDGS
No. Glenview Capital Management exited its LABORATORY CRP OF AMER HLDGS position in Q2 2023. Its Q1 2023 13F listed 50,402 shares worth $11.6M. Glenview Capital Management first reported LABORATORY CRP OF AMER HLDGS in Q2 2020 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.